目录
- Glypican-3 as a specifc biomarker for hepatocellular carcinoma
- Preoperative diabetes as a protective factor for pancreatic fstula after pancreaticoduodenectomy: a meta-analysis
- Benefcial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease
- Current strategies for preventing the recurrence of hepatocellular carcinoma after livertransplantation
- Major complications of adult right lobe living liver donors
- Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation
- sFRP-4, a potential novel serum marker for chronic hepatitis B-related hepatocellular carcinoma
- Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
- Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma
- Mesenchymal stem cells from the human umbilical cord ameliorate fulminant hepatic failure and increase survival in mice
- Contrast-enhanced ultrasound in diagnosis of gallbladder adenoma
- Mutations in thep16gene in DMBA-induced pancreatic intraepithelial neoplasia and pancreatic cancer in rats
- Inhibition of pancreatic stellate cell activity by adipose-derived stem cells
- Progression-free survival as surrogate endpoint in advanced pancreatic cancer: meta-analysis of 30 randomized frst-line trials
- Meetings and Courses
- Pentoxifylline enhances the protective effects of hypertonic saline solution on liver ischemia reperfusion injury through inhibition of oxidative stress